LobbyingQuest Diagnostics lobbying by quarter
Quest Diagnostics DGX's latest lobbying report covers Q2 2026, at $660K. The four quarters Q4 2025–Q3 2026 total $2.1M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $2.1M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $510K | 4 |
| Q1 2023 | $710K | 5 |
| Q2 2023 | $720K | 4 |
| Q3 2023 | $710K | 4 |
| Q4 2023 | $720K | 4 |
| Q1 2024 | $620K | 4 |
| Q2 2024 | $710K | 4 |
| Q3 2024 | $600K | 4 |
| Q4 2024 | $580K | 4 |
| Q1 2025 | $520K | 4 |
| Q2 2025 | $520K | 4 |
| Q3 2025 | $500K | 4 |
| Q4 2025 | $540K | 4 |
| Q1 2026 | $880K | 4 |
| Q2 2026 | $660K | 4 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$4.6M · 61 reports
- Medicare and Medicaid$3.9M · 49 reports
- Budget and appropriations$963.3K · 13 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES61 reports
- SENATE61 reports
- Health & Human Services, Dept of (HHS)17 reports
- Centers For Medicare and Medicaid Services (CMS)14 reports
- Centers For Disease Control & Prevention (CDC)4 reports
- Executive Office of the President (EOP)4 reports
- Office of Science & Technology Policy (OSTP)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseQuest Diagnostics | $6.7M | 15 quarters |
| Red+blue Strategies | $1.2M | 15 quarters |
| Tarplin, Downs & Young | $820K | 14 quarters |
| Federal Street Strategies | $750K | 15 quarters |
| King & Spalding | $80K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ANNABELL MCWHERTER STOKES | Counsel, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2020) Law Clerk, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2018) | Q2 2026 |
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner | Q2 2026 |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham | Q2 2026 |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price | Q2 2026 |
| JEFF RECZEK | Dir. CDC Washington, Professional Staff Sen. Appropriations Cmte, Program Examiner OMB, Program Analyst Dept. of Transportation | Q2 2026 |
| JENNIFER B YOUNG | Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance | Q2 2026 |
| KAADE WALLACE | Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum | Q2 2026 |
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor. | Q2 2026 |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform | Q2 2026 |
| STACEY LEAVANDOSKY | Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation | Q2 2026 |
| VEN NERALLA | Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff, U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep. Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio; Senior Advisor, USDA; OPP; and MCC. | Q2 2026 |
| LAURA FRIEDEL | Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee | Q3 2025 |
| MARGAUX OCHOA | Office of the Vice President, President, U.S. Senate | Q2 2025 |
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations, and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel, Sen. Cmte. on Finance | Q4 2024 |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. | Q4 2024 |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun | Q4 2024 |
| PARICK BRAERTON CARROLL | Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte. | Q4 2024 |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte. | Q4 2024 |
| ANDREW JONES | Legislative Director and Counsel, U.S. Representative Ben Ray Lujan; Legislative Counsel, U.S. Representative Ruben Hinojosa. | Q3 2024 |
| NATALIE ARMIJO | Chief of Staff, U.S. Rep. Michelle Lujan Grisham; and Deputy Chief of Staff, U.S. Rep. Michelle Lujan Grisham | Q3 2024 |
| ALEXANDER ("ANDER") M. CRENSHAW | U.S. Representative (FL-04), 2001-2017 | Q1 2023 |
| GEORGE C CRAWFORD | Chief of Staff: Rep. Pelosi (CA-12) | Q1 2023 |
| KENDRICK B MEEK | U.S. Representative (FL-17) 2002-2010 | Q1 2023 |
| AMIRAH SALAAM | Staff, Congressional Black Caucus - Rep. Meek (FL-17), Rep. Carson (IN-07), Rep. Payne, Sr. (NJ-10) | Q4 2022 |
| RENE MUNOZ | Chief of Staff, U.S. Representative Xochitl Torres Small; Deputy Assistant USTR for Congressional Affairs; Chief of Congressional and Intergovernmental Affairs, U.S. Census Bureau; and Chief of Staff, U.S. Representative Pete Gallego. | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Federal Street Strategies | $50K |
| 07/20for Q2 | In-house | $470K |
| 07/17for Q2 | Red+blue Strategies | $80K |
| 07/16for Q2 | Tarplin, Downs & Young | $60K |
| 04/20for Q1 | Federal Street Strategies | $50K |
| 04/20for Q1 | Red+blue Strategies | $80K |
| 04/20for Q1 | Tarplin, Downs & Young | $60K |
| 04/20for Q1 | In-house | $690K |
| 01/20for Q4 2025 | Federal Street Strategies | $50K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $60K |
| 01/20for Q4 2025 | Red+blue Strategies | $80K |
| 01/20for Q3 2025 | In-house | $310K |
| 01/20for Q2 2025 | In-house | $330K |
| 01/20for Q1 2025 | In-house | $330K |
| 01/20for Q4 2025 | In-house | $350K |
| 25/10/20for Q3 2025 | Federal Street Strategies | $50K |
| 25/10/20for Q3 2025 | In-house | $360K |
| 25/10/16for Q3 2025 | Tarplin, Downs & Young | $60K |
| 25/10/11for Q3 2025 | Red+blue Strategies | $80K |
| 25/07/21for Q2 2025 | Federal Street Strategies | $50K |